<DOC>
	<DOCNO>NCT00166881</DOCNO>
	<brief_summary>In study , investigator use P-HDFL , regimen high tumor remission rate ( ~ 60-70 % ) modest treatment-associated toxicity , induction chemotherapy patient non-resectable gastric cancer . For patient achieve complete response ( CR ) partial response ( PR ) , DI use `` consolidate '' remission . For patient fail achieve remission P-HDFL , DI use salvage chemotherapy . The efficacy toxicity DI two setting evaluate prospective study .</brief_summary>
	<brief_title>Weekly Docetaxel/Irinotecan Non-resectable Gastric Cancers After Cisplatin Plus 5-FU/Leucovorin</brief_title>
	<detailed_description>1 . To evaluate weekly Docetaxel-Irinotecan , potentially non-cross-resistant regimen , prolong overall survival ( OS ) duration remission patient achieve CR PR P-HDFL regimen 2 . To evaluate efficacy weekly Docetaxel-Irinotecan combination salvage regimen patient either fail achieve remission recur P-HDFL chemotherapy 3 . To find optimal dos docetaxel irinotecan weekly dosing schedule gastric cancer patient 4 . To evaluate toxicity weekly Docetaxel-Irinotecan regimen inoperable gastric cancer</detailed_description>
	<mesh_term>Stomach Neoplasms</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<mesh_term>Irinotecan</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Camptothecin</mesh_term>
	<criteria>1 . Histologically cytologically confirm gastric adenocarcinoma 2 . Measurable evaluable disease 3 . No previous C/T 4 . Age 16 ~ 75 year 5 . Karnofsky Performance Status 60 % 6 . 4 week R/T 7 . Adjuvant C/T : last dosing C/T 6 month enrollment 8 . WBC &gt; = 4,000 , platelet &gt; = 100K , Creatinine &lt; = 1.5mg/dl proteinuria &lt; 1+ , normal serum bil , transaminase &lt; = 3.5x ULN , TG &gt; 70mg/dl 1 . CNS metastasis 2 . Patients receive concomitant anticancer C/T R/T 3 . Patients pregnant expect life expectancy le 3 month 4 . Symptomatic heart disease , active infection , extensive liver disease , liver cirrhosis</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>Combination , Chemotherapy , Inoperable Gastric Cancer</keyword>
</DOC>